These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 382150)

  • 21. Effects of intravenous and oral domperidone on the motor function of the stomach and small intestine.
    Baeyens R; van de Velde E; De Schepper A; Wollaert F; Reyntjens A
    Postgrad Med J; 1979; 55 Suppl 1():19-23. PubMed ID: 382148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind comparison of clebopride and placebo in dyspepsia secondary to delayed gastric emptying.
    Bavestrello L; Caimi L; Barbera A
    Clin Ther; 1985; 7(4):468-73. PubMed ID: 3893703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
    De Nutte N; Van Ganse W; Witterhulghe M; Defrance P
    Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of chronic postprandia dyspepsia. Crossed double-blind study with Domperidon (Motilium)].
    Englert W; Schlich D
    Fortschr Med; 1978 Jun; 96(21):1150-2. PubMed ID: 649030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Domperidone (R 33 812) as an antiemetic in the treatment of postoperative vomiting. A double blind comparison between two different dosages (4 mg and 10 mg).
    Helmers JH; van Leeuwen L
    Acta Anaesthesiol Belg; 1979 Dec; 30(4):265-72. PubMed ID: 398661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Domperidone, a novel and safe gastrokinetic anti-nauseant for the treatment of dyspepsia and vomiting.
    Reyntjens AJ; Niemegeers CJ; Van Nueten JM; Laduron P; Heykants J; Schellekens KH; Marsboom R; Jageneau A; Broekaert A; Janssen PA
    Arzneimittelforschung; 1978; 28(7):1194-6. PubMed ID: 582708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Domperidon--a new gastrokinetic and anti-emetic without central-nervous side effects].
    Gnauen H
    Med Klin; 1980 Jun; 75(12):453-8. PubMed ID: 7393112
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia.
    Sawant P; Das HS; Desai N; Kalokhe S; Patil S
    J Assoc Physicians India; 2004 Aug; 52():626-8. PubMed ID: 15847356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial.
    Corazza GR; Biagi F; Albano O; Bianchi Porro G; Cheli R; Mazzacca G; Miglio F; Naccarato R; Quaglino D; Surrenti C; Verme G; Gasbarrini G
    Ital J Gastroenterol; 1996; 28(6):317-23. PubMed ID: 8891846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of domperidone in the treatment of chronic postprandial idiopathic upper gastrointestinal distress.
    Nagler J; Miskovitz P
    Am J Gastroenterol; 1981 Dec; 76(6):495-9. PubMed ID: 7036711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
    Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D
    Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
    Halter F; Staub P; Hammer B; Guyot J; Miazza BM
    J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome-predominant functional dyspepsia.
    Du Y; Su T; Song X; Gao J; Zou D; Zuo C; Xie W; Wang B; Zhang Z; Xu J; Tian D; Luo H; Zhang Z; Wang S; Chen J; Guo J; Gong L; Ding Y; Li Z
    J Clin Gastroenterol; 2014 Apr; 48(4):328-35. PubMed ID: 24440931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative trial between two drugs in the treatment of vomiting induced by anti-cancer chemotherapy (author's transl)].
    Zylberait D; Krulik M; Audebert AA; Debray J
    Sem Hop; 1981 Jan 8-15; 57(1-2):47-9. PubMed ID: 6258237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary report of domperidone (R 33182), a new antiemetic compound. A pilot study.
    Helmers JH
    Acta Anaesthesiol Belg; 1977; 28(4):245-50. PubMed ID: 613705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A retrospective study on the efficacy of the treatment of functional dyspepsia. An evaluation of 166 cases].
    Canepa G; Di Somma C; Arnulfo G; Frascio M; Berti Riboli E
    Minerva Med; 1991 Jun; 82(6):371-3. PubMed ID: 2067709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia.
    Kato M; Watanabe M; Konishi S; Kudo M; Konno J; Meguro T; Kitamori S; Nakagawa S; Shimizu Y; Takeda H; Asaka M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():27-31. PubMed ID: 15943843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A; Fidalgo P; Freire A; Matos L
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic functional dyspepsia: short- and medium-term outcome of a therapeutic trial with cisapride.
    Rösch W
    Clin Ther; 1994; 16(3):437-45. PubMed ID: 7923310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of domperidone (R 33812) on the motor function of the stomach and small intestine. A double-blind evaluation.
    Baeyens R; Reyntjens A; Van de Velde E
    Arzneimittelforschung; 1978; 28(4):682-6. PubMed ID: 373771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.